In November 2017, Asana Medical, Inc. announced that they had formally changed their name to Regentys, as a more distinctive representation of their business model and underlying regenerative medicine technology.

Asana Medical, Inc. to Present as Innovation Challenge Finalist at RESI Boston Conference 2017

Sept. 11, 2017

Asana has been selected as an Innovation Challenge Finalist and will present at the RESI Conference in Boston, Massachusetts on Tuesday, September 26th, 2017

Read More →

Dr. Susan G. Manella Joins Asana’s Medical Advisory Board

Aug. 25, 2017

Dr. Susan G. Manella has accepted the Company’s offer to join its Medical Advisory Board. Dr. Manella will assume the board’s leadership role in managing information flow and liaising between management and medical doctors.

Read More →

Pharmaceutical Industry Executive Brian W. Andersen Named Chief Business Officer

April 18, 2017

Brian W. Andersen, an experienced industry executive with a proven record of commercial excellence, has been appointed Chief Business Officer.

Read More →

IBD NEWS DAILY: Asana Reports Positive Preclinical Data of Treatment for Ulcerative Colitis

Oct. 17, 2016

Asana Medical has announced positive data from a preclinical study using an innovative liquid treatment called Extracellular Matrix Hydrogel (ECMH)

Read More →

Asana Medical Inc.’s Preclinical Study Indicates Promising Solution to Treat Ulcerative Colitis

Oct. 4, 2016

Company’s Patented Drug-Free, Non-Surgical Therapy Promotes Tissue Regeneration

Read More →